Stay updated on Pediatric Emicizumab SC in Hemophilia A Clinical Trial
Sign up to get notified when there's something new on the Pediatric Emicizumab SC in Hemophilia A Clinical Trial page.

Latest updates to the Pediatric Emicizumab SC in Hemophilia A Clinical Trial page
- Check7 days agoChange DetectedThe site footer revision label changes from v3.7.1 to v3.7.2, while the study page continues to display a 403 Forbidden error.SummaryDifference0.2%

- Check13 days agoChange DetectedThe footer’s site revision identifier changed from v3.7.0 to v3.7.1 on the 403 Forbidden page, while the study record remains unavailable.SummaryDifference0.2%

- Check21 days agoNo Change Detected
- Check35 days agoChange Detected403 Forbidden page now appears for the study, replacing the prior study record content and links to documents. The study description and related documents have been removed, leaving only the header and footer with the error message.SummaryDifference22%

- Check56 days agoChange DetectedThe page's revision label was updated to v3.6.6, replacing the previous v3.6.5, indicating a minor backend/content update.SummaryDifference0.0%

- Check63 days agoChange DetectedAdded a new line under Other Study ID Numbers: 2016 ( U.S. NIH Grant/Contract ), recording NIH funding for the study and updating the list of identifiers. This addition reflects the funding attribution associated with the trial and integrates it into the standard identifiers presented on the page.SummaryDifference0.0%

- Check77 days agoChange DetectedThe page now displays Revision: v3.6.5, replacing v3.6.4. This reflects a small version update to the page without changes to the study details.SummaryDifference0.0%

Stay in the know with updates to Pediatric Emicizumab SC in Hemophilia A Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Emicizumab SC in Hemophilia A Clinical Trial page.